Elevance Health, Inc.

ELV

Share price not shown yet: live market data is not connected. Everything below comes from ELV’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Revenue growth
+6.3%
TTM vs prior TTM
ROE (TTM)
11.2%
TTM NI ÷ avg equity
Net debt
-$4.9B
total debt − cash & ST inv.
Dilution (YoY)
-3.7%
negative = buybacks
SBC / revenue
0.1%
TTM revenue
$201B

Revenue

$0B$10B$20B$30B$40B$50BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$50B

EPS (diluted)

$0.00$2.00$4.00$6.00$8.00$10.00Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$6.71

Margins

GrossOperating
0%20%40%60%80%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’2689%

Net income

$0.0B$0.5B$1.0B$1.5B$2.0BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$1.5B

Net margin

1.0%2.0%3.0%4.0%5.0%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’262.9%

Free cash flow vs. stock-based comp

FCFSBC
-$4B-$2B$0B$2B$4B$6BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$2B

Operating cash flow vs. capex

OCFCapex
-$2B$0B$2B$4B$6BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$2B

SG&A

$0B$2B$4B$6BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$6B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…